olivlawolivlaw

olivLaw · US equity research

Solstice Advanced Materials Inc. SOLS

Chemicals & Allied Products · SIC 2800 · Vertical: Chemicals & Allied Products (SIC 2800)

57.70USD−6.54% · 1 dayClose 04 Nov 2026

Solstice Advanced Materials is a global advanced materials company and a leading supplier of low global warming potential refrigerants, semiconductor materials and conversion services for the nuclear energy sector. The company was spun off from Honeywell in October 2025 and trades on Nasdaq as SOLS; in July 2026 it announced the acquisition of Element Solutions, a deal that could reshape its profile. Sales grew in the first half of 2026 and full-year guidance was raised.

The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).

At the close of 04 Nov 2026, Solstice Advanced Materials Inc. (SOLS) stock was 57.70 USD (−6.54% on the day), with market capitalisation 9.1 bn USD, P/E 28.3 on diluted EPS of 2.04 USD over the last 12 months, dividend yield 16.93%, beta 1.47, 52-week range 41.43–88.60 USD. Latest reported quarter (Q3 2026): revenue of 1.0 bn USD (+7.9% YoY), net income of 80.0 m USD, diluted EPS 0.50 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
9.1 bn USD
shares as of 28 Oct 2026
P/E (TTM)
28.3
Diluted EPS TTM 2.04 · TTM to 30 Sept 2026
E/P (TTM)
3.53%
TTM to 30 Sept 2026
Dividend yield
16.93%
Beta (2y)
1.47
Volatility (1y) 55%
52-week range
41.4388.60

Price history

Loading chart…

Technical reading

RSI (14)
43.6
weak (30–45)
Bollinger (20, 2)
57.52 – 64.31
in the lower half of the band · %B 0.03 · band width 11.2%
SMA 50 / 200
59.94 / 70.17
downtrend (price < SMA50 < SMA200)
MACD (12, 26, 9)
0.15 / 0.46
MACD below signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month−0.6%−1.1%+0.5 pp—
3 months−7.7%−0.5%−7.2 pp—
6 months−29.6%+4.4%−34.0 pp—
Year to date+18.8%+12.3%+6.5 pp—
1 year+32.2%+13.5%+18.6 pp+0.8%
3 yearsunavailable+76.4%unavailable−36.5%
5 yearsunavailable+63.7%unavailable—
Max drawdown (1y)
−37.5%
30 Jun 2026 → 24 Aug 2026
Max drawdown (5y)
−37.5%
30 Jun 2026 → 24 Aug 2026
Compound annual growth (5y)
unavailable
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q3 2026 · 30 Sept 2026

Revenue
1.0 bn USD
+7.9% YoY
Net income
80.0 m USD
unavailable YoY
Diluted EPS
0.50
unavailable YoY
net / operating
7.6% / unavailable

Quarterly margins

Quarterly statements · USD

Fiscal yearQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Revenue913.0 m897.0 m1.0 bn969.0 m987.0 m991.0 m1.1 bn1.0 bn
Cost of revenue608.0 m577.0 m671.0 m659.0 m729.0 m675.0 m778.0 m701.0 m
Research & development21.0 m22.0 m23.0 m26.0 m27.0 m28.0 m25.0 m30.0 m
SG&A89.0 m93.0 m105.0 m113.0 m112.0 m108.0 m123.0 m120.0 m
Interest expense2.0 m1.0 m2.0 m2.0 m23.0 m29.0 m23.0 m60.0 m
Pre-tax income176.0 m188.0 m199.0 m173.0 m86.0 m136.0 m176.0 m112.0 m
Income tax42.0 m47.0 m101.0 m182.0 m32.0 m31.0 m42.0 m24.0 m
Net income133.0 m134.0 m97.0 m-35.0 m41.0 m85.0 m119.0 m80.0 m
Diluted EPS—0.850.61-0.220.26 ≈0.530.750.50
Operating cash flow275.0 m160.0 m150.0 m ≈-21.0 m ≈166.0 m199.0 m262.0 m ≈232.0 m ≈
Capex95.0 m62.0 m76.0 m ≈110.0 m ≈88.0 m75.0 m138.0 m ≈112.0 m ≈
Dividends paid—00 ≈0 ≈1.5 bn12.0 m12.0 m ≈12.0 m ≈

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 25 percentile of its own 4-quarter history (min 27.6, median 48.6, max 67.3; quarters with earnings only).

Fiscal years

Fiscal year202320242025
Revenue3.6 bn3.8 bn3.9 bn
Revenue YoYunavailable+3.3%+3.1%
Net income621.0 m594.0 m237.0 m
Net income YoYunavailable−4.3%−60.1%
Diluted EPS3.913.741.49
Diluted EPS YoYunavailable−4.3%−60.2%
net %17.0%15.8%6.1%
Free cash flow461.0 m546.0 m119.0 m

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
534.0 m USD
Financial debt
2.0 bn USD
Net debt
1.4 bn USD
Equity
1.4 bn USD
Total assets
5.7 bn USD
Debt / equity
1.43x
Current ratio
1.39x
ROE
10.4%
ROA
4.4%
FCF margin
3.1%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2023
3.6 bn
2024
3.8 bn
2025
3.9 bn

SEC (XBRL)· 19 Feb 2026verified

Cost of revenue
2023
2.4 bn
2024
2.5 bn
2025
2.6 bn

SEC (XBRL)· 19 Feb 2026verified

Gross profit
2023
1.3 bn ≈
2024
1.3 bn ≈
2025
1.3 bn ≈

SEC (XBRL)· 19 Feb 2026derived

Research & development
2023
81.0 m
2024
83.0 m
2025
97.0 m

SEC (XBRL)· 19 Feb 2026verified

SG&A
2023
378.0 m
2024
392.0 m
2025
421.0 m

SEC (XBRL)· 19 Feb 2026verified

Depreciation & amortisation
2023
48.0 m
2024
39.0 m
2025
24.0 m

SEC (XBRL)· 19 Feb 2026verified

Interest expense
2023
16.0 m
2024
13.0 m
2025
28.0 m

SEC (XBRL)· 19 Feb 2026verified

Pre-tax income
2023
814.0 m
2024
797.0 m
2025
647.0 m

SEC (XBRL)· 19 Feb 2026verified

Income tax
2023
195.0 m
2024
192.0 m
2025
362.0 m

SEC (XBRL)· 19 Feb 2026verified

Net income
2023
621.0 m
2024
594.0 m
2025
237.0 m

SEC (XBRL)· 19 Feb 2026verified

Diluted EPS
2023
3.91
2024
3.74
2025
1.49

SEC (XBRL)· 19 Feb 2026verified

Weighted average diluted shares
2023
158.7 m
2024
158.7 m
2025
158.9 m

SEC (XBRL)· 19 Feb 2026verified

Balance sheet · USD

Cash
2023
606.0 m
2024
661.0 m
2025
534.0 m

SEC (XBRL)· 19 Feb 2026verified

Receivables
2023
—
2024
569.0 m
2025
645.0 m

SEC (XBRL)· 19 Feb 2026verified

Inventories
2023
—
2024
558.0 m
2025
715.0 m

SEC (XBRL)· 19 Feb 2026verified

Current assets
2023
—
2024
1.9 bn
2025
2.4 bn

SEC (XBRL)· 19 Feb 2026verified

Property, plant & equipment, net
2023
—
2024
1.7 bn
2025
2.1 bn

SEC (XBRL)· 19 Feb 2026verified

Goodwill
2023
814.0 m
2024
806.0 m
2025
820.0 m

SEC (XBRL)· 19 Feb 2026verified

Intangibles (excl. goodwill)
2023
—
2024
35.0 m
2025
49.0 m

SEC (XBRL)· 19 Feb 2026verified

Total assets
2023
—
2024
5.0 bn
2025
5.7 bn

SEC (XBRL)· 19 Feb 2026verified

Accounts payable
2023
—
2024
778.0 m
2025
909.0 m

SEC (XBRL)· 19 Feb 2026verified

Short-term debt
2023
—
2024
0
2025
4.0 m

SEC (XBRL)· 19 Feb 2026verified

Long-term debt
2023
—
2024
0
2025
2.0 bn

SEC (XBRL)· 19 Feb 2026verified

Current liabilities
2023
—
2024
1.1 bn
2025
1.7 bn

SEC (XBRL)· 19 Feb 2026verified

Total liabilities
2023
—
2024
1.8 bn
2025
4.3 bn

SEC (XBRL)· 19 Feb 2026verified

Equity
2023
3.0 bn
2024
3.2 bn
2025
1.4 bn

SEC (XBRL)· 19 Feb 2026verified

Cash flow · USD

Operating cash flow
2023
760.0 m
2024
842.0 m
2025
455.0 m

SEC (XBRL)· 19 Feb 2026verified

Capex
2023
299.0 m
2024
296.0 m
2025
336.0 m

SEC (XBRL)· 19 Feb 2026verified

Free cash flow
2023
461.0 m ≈
2024
546.0 m ≈
2025
119.0 m ≈

SEC (XBRL)· 19 Feb 2026derived

Investing cash flow
2023
-324.0 m
2024
-298.0 m
2025
-330.0 m

SEC (XBRL)· 19 Feb 2026verified

Financing cash flow
2023
-378.0 m
2024
-453.0 m
2025
-235.0 m

SEC (XBRL)· 19 Feb 2026verified

Dividends paid
2023
0
2024
0
2025
1.5 bn

SEC (XBRL)· 19 Feb 2026verified

Computed indicators

Growth

Revenue growth (YoY)
3.1%
computed by olivLawFY 2025
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
unavailable
input data missing
Net income growth (YoY)
-60.1%
computed by olivLawFY 2025
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
-60.2%
computed by olivLawFY 2025
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
-78.2%
computed by olivLawFY 2025

Profitability

Gross margin
30.9%
computed by olivLawTTM to 30 Sept 2026
EBITDA margin
unavailable
input data missing
EBIT margin
unavailable
input data missing
Net margin
7.8%
computed by olivLawTTM to 30 Sept 2026
FCF margin
10.7%
computed by olivLawTTM to 30 Sept 2026

Returns

ROE
13.6%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROA
5.7%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROIC
unavailable
input data missing
ROCE
unavailable
input data missing
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
344.4%
computed by olivLawTTM to 30 Sept 2026

Balance sheet

Net debt
1.3 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
Net debt / EBITDA
unavailable
input data missing
Debt / equity
1.3x
computed by olivLawbalance sheet at 30 Sept 2026
Interest coverage
unavailable
input data missing

Liquidity

Current ratio
1.4x
computed by olivLawbalance sheet at 30 Sept 2026
Quick ratio
1.0x
computed by olivLawbalance sheet at 30 Sept 2026
Cash ratio
0.4x
computed by olivLawbalance sheet at 30 Sept 2026

Cash

Operating cash flow
859.0 m USD
computed by olivLawTTM to 30 Sept 2026
Capital expenditure
413.0 m USD
computed by olivLawTTM to 30 Sept 2026
Free cash flow
446.0 m USD
computed by olivLawTTM to 30 Sept 2026
FCF conversion
137.2%
computed by olivLawTTM to 30 Sept 2026
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
57 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Days inventory outstanding
88 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Days payables outstanding
116 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Cash conversion cycle
30 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026

Market and valuation

Market capitalisation
9.1 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
Enterprise value
10.3 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
Market cap / net income TTM
27.9x
computed by olivLawTTM to 30 Sept 2026
P/E (TTM)
28.3x
computed by olivLawTTM to 30 Sept 2026
Earnings yield
3.5%
computed by olivLawTTM to 30 Sept 2026
P/B
5.8x
computed by olivLawbalance sheet at 30 Sept 2026
P/S
2.2x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
2.5x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
P/FCF
20.3x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
FCF yield
4.9%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Dividend yield
16.9%
computed by olivLawTTM to 30 Sept 2026
Shareholder yield (distributions)
16.9%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026

Risk

Altman Z
unavailable
input data missing

Valuation

olivLaw classification

Insufficient data
What is missing
  • score weight coverage: 45.8% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

57.70 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 9.1 bn USD

Key indicators

Market capitalisation
9.1 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
P/E (TTM)
28.3x
computed by olivLawTTM to 30 Sept 2026
P/B
5.8x
computed by olivLawbalance sheet at 30 Sept 2026
EV/EBITDA
unavailable
input data missing
ROE
13.6%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Net margin
7.8%
computed by olivLawTTM to 30 Sept 2026
Revenue growth (YoY)
3.1%
computed by olivLawFY 2025
Dividend yield
16.9%
computed by olivLawTTM to 30 Sept 2026

Coverage and freshness

32/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 30 Sept 2026
Latest balance sheet date: 30 Sept 2026
Share count (cover of the latest filing), as of: 28 Oct 2026
Source: SEC (XBRL)published 04 Nov 2026
verified 331derived 25

Score by group

46% · Insufficient data

Estimated value range

Low
45.45
USD per share
Mid
61.44
USD per share
High
78.99
USD per share
Price: 57.70 USD
The price is within the range
Potential to the central value: 6.5% (value / price − 1)
Margin of safety: 6.1% (1 − price / value)
Agreement between methods: high · 2 methods used · 2 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 41.38 – 86.00 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)41.38 – 71.98 (Mid 52.84)
    WACC 8.4% · starting FCFF 546.9 m USD · terminal value share of EV 76%
    The WACC × g sensitivity gives the method's bounds; these are not probabilities.
    Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): 6.5%
  • Peers: EV/EBITDAunavailable · input data missing
  • Peers: P/E49.51 – 86.00 (Mid 70.04)
    3 companies used · median multiple 34.4x · quartiles 24.3x – 42.2x
    BCPC, IOSP, NGVT
  • Dividend discount (DDM)unavailable · input data missing
Multiple comparisons use the SIC vertical: Chemicals & Allied Products (SIC 2800)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Insufficient data

Minimum-evidence gate: score weight coverage: 45.8% of at least 60%

FactorValueScoreWeight used
ROIC · Qualityunavailableunavailable—
Net margin · Quality7.8%93 (vs peers)14%
FCF conversion · Quality137.2%100 (on a fixed band)14%
Revenue CAGR 3Y · Growthunavailableunavailable—
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheetunavailableunavailable—
Current ratio · Balance sheet1.4x49 (on a fixed band)9%
P/E (TTM) · Valuation28.3x8 (on a fixed band)23%
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuation4.9%61 (on a fixed band)18%
Shareholder yield (distributions) · Returns16.9%100 (on a fixed band)14%
Payout ratio (FCF) · Returns344.4%0 (on a fixed band)9%

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet· partial49/100 · 1/3 factors with a value
  • Growth· partialunavailable · 0/2 factors with a value
  • Quality96/100 · 2/3 factors with a value
  • Returns60/100 · 2/2 factors with a value
  • Valuation32/100 · 2/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

Solstice Advanced Materials Inc. (SOLS). Latest full fiscal year: 2025; data up to 2026-09-30.

Figures computed from the financial statements: revenue 3.9 bn USD in 2025; YoY growth 3.1%; net margin 7.8%; ROE 13.6%.

The estimated value range is 45.45–78.99 USD per share (median of 2 methods, agreement: high); assumptions are illustrative. Against the central value of 61.44 USD, the price of 57.70 USD leaves a potential of 6.5% (value / price − 1) and a margin of safety of 6.1% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

Insufficient data for a verdict (score weight coverage: 45.8% of at least 60%).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • Net margin: 7.8%
  • FCF conversion: 137.2%
  • Shareholder yield (distributions): 16.9%

What contradicts it

  • P/E (TTM): 28.3x
  • Payout ratio (FCF): 344.4%

Not assessed (insufficient data or a ratio without meaning): ROIC, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, EV/EBITDA.

Versus the vertical median

Chemicals & Allied Products (SIC 2800) · same industry (4-digit SIC) · compared with 14 companies

Multiples and returns vs the median

P/E
28.3x
vertical median 34.4x
below median (−17.6%)
EV/EBITDA
—
vertical median 8.6x
P/S
2.2x
vertical median 1.3x
above median (+73.2%)
P/B
5.8x
vertical median 1.7x
above median (+242.6%)
ROE
13.6%
vertical median -12.2%
above median
Net margin
7.8%
vertical median -6.4%
above median
EBIT margin
—
vertical median -3.0%
Revenue YoY
3.1%
vertical median -1.1%
above median
Net debt/EBITDA
—
vertical median 2.3x
Dividend yield
16.9%
vertical median 3.5%
above median (+386.4%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
SOLSSolstice Advanced Materials Inc.9.1 bn28.313.6%7.8%+3.1%+32% / unavailable
BCPCBalchem Corporation5.8 bn34.413.0%15.4%+8.8%+17% / +46%
PRMPerimeter Solutions, Inc.4.6 bn—-30.9%-44.9%+16.4%+1% / +575%
NGVTIngevity Corporation2.5 bn50.164.4%4.7%−2.7%+41% / +90%
CCThe Chemours Company2.1 bn—-339.7%-5.2%+0.4%+8% / −50%
OLNOlin Corporation2.1 bn—-12.2%-3.3%+3.7%−14% / −62%
IOSPInnospec Inc.2.0 bn14.210.5%7.5%−3.7%+8% / −23%
HUNHuntsman Corporation1.7 bn—-11.8%-5.8%−5.8%−5% / −60%
ECVTEcovyst Inc.1.1 bn—-9.6%-7.1%+20.9%+8% / +5%
FMCFmc Corporation998.7 m—-226.7%-151.2%−18.3%−55% / −88%
ACNTAscent Industries Co.124.0 m—-1.1%-1.0%−7.2%−3% / +68%
CITRCitroTech Inc.54.8 m—-431.0%-1,788.4%+194.6%unavailable / unavailable
LOOPLoop Industries, Inc.13.0 m——-2,154.3%−95.3%−77% / −92%
GUREGulf Resources, Inc.5.6 m—-32.4%-134.4%+231.8%+3% / −80%
ADURAduro Clean Technologies Inc.——-133.8%-5,253.1%−31.5%−26% / unavailable

1- and 3-year price returns: for SOLS from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
34.12
Total return -41% · Per year -41%
60.36
Total return 5% · Per year 5%
90.97
Total return 58% · Per year 58%
3 years
32.17
Total return -44% · Per year -18%
64.13
Total return 11% · Per year 4%
106.26
Total return 84% · Per year 23%
5 years
30.34
Total return -47% · Per year -12%
68.14
Total return 18% · Per year 3%
124.12
Total return 115% · Per year 17%
What moves the 3-year price the most
  • Exit P/E± 16.03
  • Net margin± 11.22
  • Annual revenue growth± 9.34
  • Annual dilution± 0.94

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

Possibly outdated: the newest document it read is from 30 Jul 2026; since then the company filed 8-K (04 Nov 2026 · results), 10-Q (04 Nov 2026).

In brief

Solstice Advanced Materials is a global advanced materials company and a leading supplier of low global warming potential refrigerants, semiconductor materials and conversion services for the nuclear energy sector. The company was spun off from Honeywell in October 2025 and trades on Nasdaq as SOLS; in July 2026 it announced the acquisition of Element Solutions, a deal that could reshape its profile. Sales grew in the first half of 2026 and full-year guidance was raised.

SWOT

Strengths

  • The company holds leading positions in high value-added niches, an extensive patent portfolio and long-standing customer relationships averaging more than ten years.
  • The operating model and proximity to customers support high margins and the ability to deliver customized solutions.
  • Sales growth in the first half of 2026 and the raised guidance point to positive business momentum.

Weaknesses

  • The company has limited history as an independent listed entity, and its historical data reflect allocations made by Honeywell.
  • The RAS segment's Adjusted EBITDA margin fell in the second quarter because of plant maintenance and prior-year effects.
  • Separation and standalone costs raised expenses and weighed on net income.

Opportunities

  • The Element Solutions acquisition could extend the company into a larger advanced materials platform with access to new markets.
  • Investment in artificial intelligence, data centers and semiconductors could increase demand for the company's materials.
  • Capacity expansion could allow the company to serve demand that currently exceeds existing production capacity.

Threats

  • Tariffs and trade tensions can raise costs and disrupt raw material supply.
  • Regulation of fluorinated chemistries could reduce demand for some products in the portfolio.
  • Competitive pressure can lead to lower prices and market share losses, especially in standardized segments.

Risks

  • Element Solutions integrationhigh

    The transaction is subject to shareholder and regulatory approvals and could face delays or may not close on the expected terms.

  • Higher indebtednesshigh

    Acquisition financing could increase total debt and reduce financial flexibility if operating results decline.

  • Raw material costs and inflationmedium

    Raw material price swings and inflationary pressures can affect margins if they cannot be passed on fully to customers.

  • Regulation and tariffsmedium

    Regulatory changes and trade policies can impose additional costs or require product changes.

  • Public perception of nuclear energylow

    Public and political attitudes toward nuclear energy and radioactive materials could negatively affect some business lines.

Investment thesis

What would need to be true (bull case)

  • If sales growth and margin expansion hold, the company could justify its raised guidance and benefit from structural demand in semiconductors and sustainability.
  • The Element Solutions acquisition could turn the company into a larger platform with access to new technology niches.
  • Long customer relationships and the patent portfolio could support recurring revenue and pricing power.

What would break the thesis

  • Higher debt after the acquisition could limit flexibility and slow investment if the deal runs into obstacles.
  • RAS segment margins have declined, and a return to prior levels is not assured if cost pressure persists.
  • Tariffs, geopolitical tensions and regulatory changes could disrupt supply and weigh on demand in several markets.

What to watch

  • Quarterly results and delivery against 2026 guidanceQ3 2026
  • Status of approvals and completion of the Element Solutions acquisitionfirst half 2027
  • Issuance of permanent debt and trend in net leverage ratio2027
  • Evolution of RAS segment Adjusted EBITDA margin in the second half of the yearnext 10-K

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

Possibly outdated: the newest document it read is from 30 Jul 2026; since then the company filed 8-K (04 Nov 2026 · results), 10-Q (04 Nov 2026).

The business

Solstice operates through two segments: Refrigerants & Applied Solutions (RAS), which makes low global warming potential refrigerants, blowing agents, solvents and aerosol materials, along with conversion services for the nuclear sector, and Electronic & Specialty Materials (ESM), which supplies electronic materials, high-strength fibers and laboratory life science chemicals. In fiscal 2025 the company reported net sales of 3886 million USD, and over 3000 customers in about 120 countries and territories formed its commercial base. The patent portfolio exceeds 5700 issued patents and pending applications, supporting its position as an innovator in high value-added niches. The company was separated from Honeywell through a distribution of shares to Honeywell's shareowners, completed on October 30, 2025.

The Solstice operating model, described as a set of practices applied across the organization, focuses on innovation and commercialization, commercial excellence, capital deployment, supply chain and manufacturing excellence. The company says it sustains high Adjusted EBITDA margins through differentiated products and proximity to customers, with 20 manufacturing sites and four standalone R&D centers. Capital expenditures represented 10% of net sales in 2025, and management expects them to remain at or above this level in the near term to expand capacity. Standalone costs from the separation from Honeywell were significant and are expected to continue at least through fiscal 2026.

Segments

Refrigerants & Applied Solutions (RAS)

The RAS segment generated net sales of 2789 million USD in fiscal 2025, and in the second quarter of 2026 its sales reached 850 million USD, up 12% year over year. Refrigerants grew 13% and the nuclear business 27%, while healthcare packaging recovered after destocking in the second half of 2025. Segment Adjusted EBITDA margin fell to 32.9% because of planned plant turnaround timing and production incentive credits in the prior year, and management expects mid-30% margins for the segment in the second half of 2026.

Market context

The company operates in markets for cooling, air conditioning and refrigeration, automotive, nuclear energy, building insulation, healthcare, semiconductors, defense and pharmaceuticals. Fiscal 2025 net sales of 3886 million USD reflect demand supported by sustainability policies, nuclear energy investment and semiconductor production. The refrigerant market, however, depends on regulation of fluorinated chemistries, which could change demand for certain products.

Management describes a volatile macroeconomic environment marked by geopolitical tensions, shifting trade and tariff policies and inflationary pressures. These factors can affect raw material costs and supply chains, and their impact on sales depends on how the global economy develops.

Trends

  • Low global warming potential refrigerant regulationtailwind

    The transition to regulatory-compliant next-generation refrigerants supports demand for the company's products as end markets move away from earlier generations.

  • Investment in nuclear energymixed

    Growth in the nuclear sector, including conversion services, has lifted divisional sales, but revenue can be uneven because some large transactions do not recur from one year to the next.

  • Semiconductor industry demandtailwind

    Chip production, artificial intelligence, data centers and semiconductor manufacturing support demand for the company's electronic materials.

  • Tariff and trade pressuresheadwind

    Import tariffs, trade restrictions and geopolitical tensions can raise costs and disrupt supply chains, particularly if measures change frequently.

Competitive position

The company builds its position on technology, product quality and proximity to customers, but warns that competitive pressure can lead to lower prices, margins or market share. Competition in advanced materials and specialty chemicals is intense, and technological advantages can erode if rivals develop similar products.

The company also flags risks linked to joint ventures and co-development partnerships, as well as competition from illegal or counterfeit products in regulated markets. These could affect sales if not managed well.

  • Element Solutions Inc

    Company Solstice agreed to acquire in July 2026; the competitive relationship would change if the transaction is completed.

  • Honeywell International Inc

    Former parent that spun off the advanced materials business; the current relationship runs through transition and licensing agreements.

  • Specialty chemicals producers

    Competitors in laboratory chemicals and electronic materials referred to generically in the company's filings.

  • Refrigerant producers

    Firms active in the low global warming potential refrigerant market, where competition could pressure prices and margins.

News & filings

In the press

SEC filings

Sources

  1. [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Solstice Advanced Materials Inc. · 19 Feb 2026
  2. [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Solstice Advanced Materials Inc. · 30 Jul 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / Solstice Advanced Materials Inc. · 30 Jul 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.